Some plans may pay for semaglutide, but some do not, especially if you use it for weight loss
Larger and longer-term studies will give a clearer picture of its safety, tolerability, and how it compares in real-world use
bs-10394R
Experts say patients taking GLP-1-based medications should monitor for mood changes and report symptoms such as: New or worsening depression Anxiety or emotional changes Suicidal thoughts More research is needed to determine whether these drugs directly affect mood or whether changes are related to factors such as rapid weight loss, hormonal changes or other metabolic effects
In the first weeks, it feels like external pressure, a force reducing your desire to eat
A PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial